MCG In Long QT Syndrome

Overview

About this study

The primary objective of this observational study is to evaluate whether magnetocardiography (MCG) findings more accurately predict clinical outcomes in patients with acquired Long QT syndrome compared to ECG. The secondary objective is to assess differences in QT interval length between MCG and ECG. The primary safety objective is to characterize the safety profile of the CardiAQ MCG device.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Age ≥ 18 years on the date of consent.

  • Ability for participant to comply with study requirements.

  • Written informed consent

  • Confirmed diagnosis of atrial fibrillation and receiving dofetilide for rhythm control in the inpatient setting.

Exclusion Criteria:

  • Pregnant or breastfeeding

  • Active thoracic metal implants (including pacemaker, insertable cardiac monitor, or internal defibrillators).

  • External electrical pads or devices (e.g. Pacer pads, ECG electrodes, heart rate patch), that must remain on patient’s chest during MCG scan.

  • Inability to lie down in a supine/inclined position and stay still on the examination bed.

  • Clinical conditions that in the opinion of the Investigator would compromise the safety of the patient or ability to complete the protocol.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 7/25/2025. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Mohamad Adnan Alkhouli

Open for enrollment

Contact information:

Mohamad Adnan Alkhouli

(507) 255-6670

Alkhouli.Mohamad@mayo.edu

More information

Publications

Publications are currently not available